This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Cantargia Future Growth
Future criteria checks 3/6
Key information
79.2%
Earnings growth rate
51.1%
EPS growth rate
| Biotechs earnings growth | 38.7% |
| Revenue growth rate | 108.0% |
| Future return on equity | 43.3% |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 220 | 158 | 158 | 158 | 1 |
| 12/31/2023 | 271 | -158 | 168 | 168 | 3 |
| 12/31/2022 | N/A | -401 | -403 | -403 | 3 |
| 3/31/2022 | N/A | -411 | -406 | -406 | N/A |
| 12/31/2021 | N/A | -367 | -347 | -346 | N/A |
| 9/30/2021 | N/A | -319 | -302 | -301 | N/A |
| 6/30/2021 | N/A | -255 | -231 | -230 | N/A |
| 3/31/2021 | N/A | -206 | -187 | -186 | N/A |
| 12/31/2020 | N/A | -173 | -165 | -156 | N/A |
| 9/30/2020 | N/A | -153 | -165 | -149 | N/A |
| 6/30/2020 | N/A | -139 | -151 | -135 | N/A |
| 3/31/2020 | N/A | -127 | -144 | -129 | N/A |
| 12/31/2019 | N/A | -111 | -118 | -111 | N/A |
| 9/30/2019 | N/A | -102 | -97 | -97 | N/A |
| 6/30/2019 | N/A | -98 | -92 | -92 | N/A |
| 3/31/2019 | N/A | -101 | -88 | -88 | N/A |
| 12/31/2018 | N/A | -91 | -105 | -105 | N/A |
| 9/30/2018 | N/A | -78 | -72 | -72 | N/A |
| 6/30/2018 | N/A | -68 | -65 | -65 | N/A |
| 3/31/2018 | N/A | -56 | -54 | -54 | N/A |
| 12/31/2017 | N/A | -60 | -41 | -41 | N/A |
| 9/30/2017 | N/A | -65 | -69 | -69 | N/A |
| 6/30/2017 | N/A | -66 | -64 | -64 | N/A |
| 3/31/2017 | N/A | -58 | -54 | -54 | N/A |
| 12/31/2016 | N/A | -47 | -42 | -42 | N/A |
| 9/30/2016 | N/A | -34 | -28 | -26 | N/A |
| 6/30/2016 | N/A | -24 | -23 | -21 | N/A |
| 3/31/2016 | N/A | -22 | -20 | -19 | N/A |
| 12/31/2015 | N/A | -17 | N/A | -30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CANTA BTA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CANTA BTA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CANTA BTA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CANTA BTA's revenue (108% per year) is forecast to grow faster than the Swedish market (9.3% per year).
High Growth Revenue: CANTA BTA's revenue (108% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CANTA BTA's Return on Equity is forecast to be very high in 3 years time (43.3%).